Phenotypic_JJ
and_CC
functional_JJ
studies_NNS
of_IN
leukocytes_NNS
in_IN
human_JJ
endometrium_NN
and_CC
endometriosis_NN
._.

The_DT
aetiology_NN
of_IN
endometriosis_NN
,_,
a_DT
common_JJ
and_CC
disabling_VBG
disorder_NN
,_,
is_VBZ
presently_RB
unknown_JJ
,_,
although_IN
immune_JJ
dysfunction_NN
could_MD
allow_VB
ectopic_JJ
endometrial_JJ
fragments_NNS
to_TO
survive_VB
outside_IN
the_DT
uterine_JJ
cavity_NN
._.

These_DT
studies_NNS
investigate_VBP
the_DT
relationship_NN
between_IN
leukocyte_NN
populations_NNS
,_,
steroid_NN
hormone_NN
receptor_NN
expression_NN
,_,
proliferative_JJ
activity_NN
,_,
bcl-2_NN
expression_NN
and_CC
apoptosis_NN
in_IN
eutopic_JJ
and_CC
ectopic_JJ
endometrium_NN
from_IN
women_NNS
with_IN
endometriosis_NN
or_CC
adenomyosis_NN
at_IN
different_JJ
phases_NNS
of_IN
the_DT
menstrual_JJ
cycle_NN
._.

Significantly_RB
increased_VBN
estrogen_NN
receptor_NN
expression_NN
,_,
bcl-2_NN
expression_NN
and_CC
numbers_NNS
of_IN
CD8_NN
+_CC
leukocytes_NNS
were_VBD
found_VBN
in_IN
ectopic_JJ
compared_VBN
with_IN
eutopic_JJ
endometrium_NN
in_IN
endometriosis_NN
,_,
and_CC
CD56_NN
+_CC
endometrial_JJ
granulated_JJ
lymphocytes_NNS
-LRB-_-LRB-
eGLs_NNS
-RRB-_-RRB-
were_VBD
significantly_RB
reduced_VBN
in_IN
ectopic_JJ
endometrium_NN
._.

Apoptotic_JJ
cells_NNS
were_VBD
rarely_RB
found_VBN
in_IN
control_NN
and_CC
subject_NN
endometria_NN
._.

In_IN
contrast_NN
with_IN
endometriosis_NN
,_,
adenomyotic_JJ
lesions_NNS
showed_VBD
identical_JJ
steroid_NN
hormone_NN
receptor_NN
expression_NN
,_,
proliferative_JJ
activity_NN
,_,
bcl-2_NN
expression_NN
and_CC
leukocyte_NN
subpopulations_NNS
to_TO
eutopic_JJ
endometrium_NN
,_,
indicating_VBG
different_JJ
aetiologies_NNS
for_IN
these_DT
disorders_NNS
._.

The_DT
unusual_JJ
CD56_NN
+_CC
CD16_NN
-_:
eGLs_NNS
present_JJ
in_IN
large_JJ
numbers_NNS
in_IN
late_JJ
secretory_JJ
phase_NN
eutopic_JJ
endometrium_NN
were_VBD
highly_RB
purified_VBN
-LRB-_-LRB-
&gt;_JJR
98_CD
%_NN
-RRB-_-RRB-
by_IN
immunomagnetic_JJ
separation_NN
._.

Except_IN
for_IN
a_DT
negligible_JJ
cytotoxic_JJ
activity_NN
of_IN
eGLs_NNS
from_IN
early_JJ
proliferative_JJ
samples_NNS
,_,
cytotoxic_JJ
activity_NN
of_IN
eGLs_NNS
from_IN
non-pregnant_JJ
endometrium_NN
during_IN
the_DT
menstrual_JJ
cycle_NN
was_VBD
comparable_JJ
with_IN
those_DT
in_IN
peripheral_JJ
blood_NN
,_,
predominantly_RB
CD56_VBG
+_CC
CD16_NN
+_CC
natural_JJ
killer_NN
cells_NNS
._.

eGLs_NNS
from_IN
non-pregnant_JJ
endometrium_NN
and_CC
early_JJ
pregnancy_NN
showed_VBD
a_DT
variable_JJ
proliferative_JJ
response_NN
to_TO
5_CD
and_CC
100_CD
U\/ml_NN
interleukin-2_NN
over_IN
48-h_JJ
and_CC
120-h_JJ
time_NN
courses_NNS
._.

eGLs_NNS
are_VBP
evidently_RB
functionally_RB
important_JJ
in_IN
the_DT
eutopic_JJ
endometrium_NN
._.

Their_PRP$
absence_NN
in_IN
endometriotic_JJ
lesions_NNS
together_RB
with_IN
increased_VBN
CD_NN
+8_NN
T-cell_NN
numbers_NNS
and_CC
increased_VBN
estrogen_NN
receptor_NN
and_CC
bcl-2_NN
expression_NN
may_MD
have_VB
significant_JJ
effects_NNS
on_IN
the_DT
development_NN
and_CC
progression_NN
of_IN
endometriosis_NN
._.

